Multimodal Biocollection Linked to the French Register of Intracranial Aneurysms
Key facts
- Who runs it
- Nantes University Hospital
- Where
- France26 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 1,100 people, planned
- Started
- 25 Mar 2025
- Expected to end
- 25 Mar 2027
- Type of study
- Interventional
- Treatments tested
- blood or saliva sample
- Record updated
- 2 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Any adult patient consulting for a definite and typical bifurcation AIC authenticated on MRI and/or cerebral arteriography
- Aneurysm discovered less than a year ago, with initial imaging (MRI and/or CTA and DSA) available
- Written consent obtained for study participation
- Patient covered by a social security plan
- Index case: Any adult patient consulting for a definite and typical bifurcation ICA presenting at least one other case with ICA related (child, parent, brother, sister) detected by MRI with at least one Time of Flight (TOF) sequence
- Family relatives: children, parents, brothers, sisters, of legal age, of patients with a family history of definite, typical bifurcation AIC (≥ 4 affected), Screening to be performed using MRI with at least a Time of Flight (TOF) sequence
- Written consent to participate in the study
- Patient and relatives covered by a social security plan
Who cannot take part
- Syndromic diagnosis known to cause ICA: Marfan syndrome, OSA with SMAD 3, Elhers Danlos syndrome type II and IV, Autosomal Dominant Cystic Fibrosis, Moya-Moya syndrome
- AIC with : Dissecting or fusiform, Associated with arteriovenous malformation, Blister-like, Mycotic
- Cerebral white matter pathology detected on MRI evoking : Col4a1 mutation
- Patient under guardianship or conservatorship
- Person under court protection
- Contraindication to an MRI scan
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The purpose of the bCAN study is to create a prospective collection of multimodal data and human samples, linked to the French Intracranial Aneurysm Registry (FRAN).
Read full original descriptionShow less
The aim of bCAN is to enable risk stratification of ruptured ICAs by redefining "intracranial aneurysm disease". The description of genotypically and phenotypically specific subgroups of cases will pave the way for improved patient management based on new diagnostic/prognostic strategies among AIC carriers, either in a familial context, or at the level of the general population.
The group in the trial
- ICA casesOther group
Any adult patient consulting for a definite and typical bifurcation AIC authenticated on MRI and/or cerebral arteriography
Treatment: blood or saliva sample
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 2 September 2026